Have a personal or library account? Click to login
Formulation and optimization of fenofibrate lipospheres using Taguchi’s experimental design Cover

Formulation and optimization of fenofibrate lipospheres using Taguchi’s experimental design

Open Access
|Mar 2013

References

  1. 1. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R. O. Quinkert, F. Martin and C. M. Goymann, Phospholipids and lipid-based formulations in oral drug delivery, Pharm. Res. 27 (2010) 1469-1486; DOI: 10.1007/s11095-010-0130-x.10.1007/s11095-010-0130-x
  2. 2. Y. C. Tseng, Y. Tabata, S. H. Hyon and Y. Ikada, In vitro toxicity test of 2 cyanoacrylate polymers by cell culture method, J. Biomed. Mater. Res. A 24 (1990) 1355-1367; DOI: 10.1002/jbm.820241007.10.1002/jbm.820241007
  3. 3. K. Lam, J. Schakenraad, H. Esselbrugge, J. Feijen and P. Nieuwenhuis, The effect of phagocytosis of poly(L -lactic acid) fragments on cellular morphology and viability, J. Biomed. Mater. Res. A27 (1993) 1569-1577; DOI: 10.1002/jbm.820271214.10.1002/jbm.820271214
  4. 4. D. B. Masters and A. J. Domb, Liposphere local anesthetic timed-release for perineural site application, Pharm. Res. 15 (1998) 1038-1045; DOI: 10.1023/A:1011978010724.10.1023/A:1011978010724
  5. 5. S. Toongsuwan, L. C. Li, B. K. Erickson and H. C. Chang, Formulation and characterization of bupivacaine lipospheres, Int. J. Pharm. 280 (2004) 57-65; DOI: 10.1016/j.bbr.2011.03.031.10.1016/j.bbr.2011.03.031
  6. 6. A. J. Domb, Long acting injectable oxytetracycline-liposphere formulations, Int. J. Pharm. 124 (1995) 271-278; DOI: 10.1016/0378-5173(95)00098-4.10.1016/0378-5173(95)00098-4
  7. 7. B. Amarji, D. Raghuwanshi, S. Vyas and P. Kanaujia, Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization, J. Biomed. Nanotechnol.3 (2007) 264-269; DOI: 10.1166/jbn.2007.029.10.1166/jbn.2007.029
  8. 8. A. Bhatia, B. Singh, V. Rani and O. Katare, Formulation, characterization, and evaluation of benzocaine phospholipid-tagged lipospheres for topical application, J. Biomed. Nanotechnol. 3 (2007) 81-89; DOI: 10.1166/jbn.2007.009.10.1166/jbn.2007.009
  9. 9. T. Bekerman, J. Golenser and A. Domb, Cyclosporin nanoparticulate lipospheres for oral administration, J. Pharm. Sci. 93 (2004) 1264-1270; DOI: 10.1002/jps.20057.10.1002/jps.2005715067702
  10. 10. N. Sateeshbabu and K. Gowthamarajan, Manufacturing techniques of lipospheres: overview, Int. J. Pharm. Pharm. Sci. 3 (2011) 17-21.
  11. 11. United States Pharmacopoeia XXXI, National Formulary XXVI, USP Convention, Rockville (MD) 2008, pp. 2145-2146.
  12. 12. J. J. Sheng, P. J. Sirois, J. B. Dressman and G. L. Amidon, Particle diffusional layer thickness in a USP dissolution apparatus II: a combined function of particle size and paddle speed, J. Pharm. Sci. 97 (2008) 4815-4829; DOI: 10.1002/jps.21345.10.1002/jps.2134518314890
  13. 13. T. Higuchi, Mechanisms of sustained action medications: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149; DOI: 10.1002/jps. 2600521210.
  14. 14. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.
  15. 15. P. Röeschlau, E. Bernt and W. Gruber, Enzymatic determination of total cholesterol in serum, Z. Klin. Chem. Klin. Biochem. 12 (1974) 403-407.
  16. 16. P. Fossati and L. Prencipe, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide, Clin. Chem. 28 (1982) 2077-2080.10.1093/clinchem/28.10.2077
  17. 17. K. D. Kim, D. N. Han and H. T Kim, Optimization of experimental conditions based on the Taguchi robust design for the formation of nano-sized silver particles by chemical reduction method, Chem. Eng. J. 104 (2004) 55-61; DOI: 10.1016/j.cej.2004.08.003.10.1016/j.cej.2004.08.003
  18. 18. L. Mu and S. S. Feng, Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers, J. Control. Release 76 (2001) 239-254; DOI: 10.1016/S0168-3659(01)00440-0.10.1016/S0168-3659(01)00440-0
  19. 19. A. Dubey, P. Prabhu and J. V. Kamath, Nano structured lipid carriers: A novel topical drug delivery system, Int. J. Pharm. Tech. Res. 4 (2012) 705-714.
  20. 20. M. Nasr, S. Mansour, N. D. Mortada and A. El. Shamy, Lipospheres as carriers for topical delivery of aceclofenac: Preparation, characterization and in vivo evaluation, AAPS PharmSciTech. 9 (2008) 154-162; DOI: 10.1208/s12249-007-9028-2.10.1208/s12249-007-9028-2297689618446476
  21. 21. M. Ozyazici, E. H. Gokçe and G. Ertan, Release and diffusional modeling of metronidazole lipidmatrices, Eur. J. Pharm. Biopharm. 63 (2006) 331-339; DOI: 10.1016/j.ejpb.2006.02.005. 10.1016/j.ejpb.2006.02.00516621486
DOI: https://doi.org/10.2478/acph-2013-0008 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 71 - 83
Published on: Mar 12, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2013 Chopparapu Saroja, Palghat Krishnamani Lakshmi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.